A biflavonoid from Luxemburgia nobilis as inhibitor of DNA topoisomerases

Planta Medica

Volumn 71, Issue 6, 2005, Pages 561-563

  Oliveira, Marcia C ^a   De Carvalho, Mario G ^a   Grynberg, Noema F ^a   Brioso, Paulo S ^a  

^a FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2'',3'' ,DIIDROOCHNAFLAVONE; BIFLAVONOID; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; QUERCETIN; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN K 562; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG STRUCTURE; EHRLICH ASCITES TUMOR; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA; MOUSE; NONHUMAN; OCHNACEAE; PLANT LEAF; SPECTROPHOTOMETRY; TITRIMETRY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIFLAVONOIDS; CELL LINE, TUMOR; DNA TOPOISOMERASES, TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; OCHNACEAE; PHYTOTHERAPY; PLANT EXTRACTS;

LUXEMBURGIA; MURINAE;

EID: 21344466554     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-864159     Document Type: Article

References (13)

1. Oliveira MCC, Carvalho MG, Silva CJ, Werle A. A New biflavonoid and other constituents from Luxembergia nobilis (EIHL). J Bras Chem Soc 2002; 13: 119-23
2. Grynberg NF, Carvalho MG, Velandia JR, Oliveira MC, Moreira IC, Braz-Filho R, Echevarria A. DNA topoisomerase inhibitors: biflavonoids from Ouratea species. Braz J Med Biol Res 2002; 35: 819-22
3. Kellner U, Rudolph P, Parwaresch R. Human DNA-topoisomerases - diagnostic and therapeutic implications for cancer. Onkologie 2000; 23: 424-30
4. Hall GD, Perren TJ. The role of topoisomerase inhibition in gynaecological oncology. Rev Gynaecol Practice 2002; 2: 29-34
5. Middleton E Jr, Kandaswami C, Theoharides CT. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 32: 673-751
6. Boege F, Straub T, Kehr A, Boesenberg C, Christiansen K, Andersen A, Jakob F, Köhrle J. Selected novel flavones inhibit the DNA binding on the DNA religation of eukaryotic topoisomerase I. J Biol Chem 1996; 271: 2262-70
7. Yamashita Y, Kawada S-Z, Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 1990; 39: 737-44
8. Quideau S, Jourdes M, Saucier C, Glories Y, Pardon P, Baudry C. DNA topoisomerase Inhibitor Acutissimin A and other flavano-ellagitannins in red wine. Angew Chem Int Ed 2003; 42: 6012-4
9. Chowdhury AR, Sharma S, Mandal S, Goswami A, Mukhopadhyay S. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem J 2002; 366: 653-61
10. Pommier Y, Covey JM, Kerrigan D, Markovits J, Pham R. DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase 1 by intercalators. Nucl Acid Res 1987; 15: 6713-31
11. Bigland C, Burgess TD, Burton JH. Guide to the care and use of experimental animals. Canada: Canadian Council on Animal Care, 1980
12. Mossman T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol 1983; 65: 55-63
13. Nandi R, Maiti M. Binding of sanguinarine to deoxyribonucleic acids of differing base composition. Biochem Pharmacol 1985; 34: 321-4